The packaging and tiers checklist: 25 things to have in place for healthcare and life sciences in North America
A single-page checklist to audit whether your packaging and tiers setup is production-grade or a science project. Written for commercial leaders at healthtech, medtech, and life-sciences companies in North America.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in North America. In this market, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed, so the way you install packaging and tiers has to be shaped to that reality from day one.
Use this as a pre-flight before you commit spend to packaging and tiers. Each item takes minutes to check and hours to fix later.
List, trigger, message. If any of the three is generic, stop and fix the generic one before you touch the other two. Generic list plus sharp message beats sharp list plus generic message, but only for a week.
Owner, cadence, metric. One named human owns the model. The cadence is written down. Average contract value by tier is the number in every review.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in North America it is compounded by the fact that signal above noise, not lead volume is what actually gates growth. Packaging and tiers is only useful here when it is pointed at both constraints at once.
Data, tooling, workflow. Data flows to one place. Tooling is minimal. Workflow survives the owner going on holiday.
Quality gate, kill criteria, learning loop. Nothing ships without a human eyeballing it. Anything below the bar dies inside a week. What you learn feeds Monday.
Ethics, brand, deliverability. You will not do anything on this list you would not want on the front page. Brand is protected. Sending infrastructure is separated from the primary domain.
Governance, budget, escalation path. Someone above the owner cares. Budget is finite and defended. Bad news travels up in hours, not weeks.
If more than three of these are missing, packaging and tiers is not going to produce a durable average contract value by tier. Fix them in order and re-run the checklist in a month.
Concretely for healthcare and life sciences in North America: the healthcare teams that install this get past procurement instead of dying in it, and the North American teams that install this land inside the first quarter, not the fourth. That is the reason it is worth installing packaging and tiers deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Pricing · healthcare · North America — answered
- Does packaging and tiers work for healthcare and life sciences in North America?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in North America, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed. The healthcare teams that install this get past procurement instead of dying in it.
- How often should I run this checklist?
- Quarterly, plus any time you change ownership, tooling, or budget for packaging and tiers.
- What is the single most important item?
- A named owner. Every other item is meaningless without one.
- What if I fail more than three items?
- Pause the spend, fix them in order, and restart at low volume rather than push through.
- Does this checklist apply at enterprise scale?
- Yes — the items are the same. Governance and escalation matter more at scale.
- What is the North America-specific pitfall when running packaging and tiers for healthcare?
- Importing a playbook that was built for another market. In North America, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed — the install has to reflect that.
Growth Broker editorial
Filed under pricing · healthcare · north america